Indian Journal of Urology Users online:5399  
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
Year : 2008  |  Volume : 24  |  Issue : 2  |  Page : 139-144

Prevention and treatment of urinary tract infection with probiotics: Review and research perspective

1 Department of Urology, St. Bartholomew's Hospital, London, United Kingdom
2 Department of Microbiology, St. Bartholomew's Hospital, London, United Kingdom
3 Department of Urology, Barking, Havering and Redbridge Hospitals, London, United Kingdom
4 Department of Urology, St. Bartholomew's Hospital; Department of Urology, Homerton University Hospitals, London, United Kingdom
5 Department of Urology, St. Bartholomew's Hospital; Department of Urology, Newham University Hospitals, London, United Kingdom

Correspondence Address:
D Borchert
Ground Floor, KGV Block, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE
United Kingdom
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0970-1591.40604

Rights and Permissions

The spiralling costs of antibiotic therapy, the appearance of multiresistant bacteria and more importantly for patients and clinicians, unsatisfactory therapeutic options in recurrent urinary tract infection (RUTI) calls for alternative and advanced medical solutions. So far no sufficient means to successfully prevent painful and disabling RUTI has been found. Even though long-term oral antibiotic treatment has been used with some success as a therapeutic option, this is no longer secure due to the development of bacterial resistance. One promising alternative is the use of live microorganisms (probiotics) to prevent and treat recurrent complicated and uncomplicated urinary tract infection (UTI). The human normal bacterial flora is increasingly recognised as an important defence to infection. Since the advent of antibiotic treatment five decades ago, a linear relation between antibiotic use and reduction in pathogenic bacteria has become established as medical conventional wisdom. But with the use of antibiotics the beneficial bacterial flora hosted by the human body is destroyed and pathogenic bacteria are selectively enabled to overgrow internal and external surfaces. The benign bacterial flora is crucial for body function and oervgrowth with pathogenic microorganisms leads to illness. Thus the concept of supporting the human body's normal flora with live microorganisms conferring a beneficial health effect is an important medical strategy.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded1307    
    Comments [Add]    
    Cited by others 19    

Recommend this journal